SCHEMBL14029307

SCHEMBL14029307

CC(=O)c1sc(Nc2ccccc2N)cc1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 7/20 0.45
MAPK13 O15264 6/20 0.45
MAPK12 P53778 6/20 0.45
MAPK11 Q15759 6/20 0.45
MAPT P10636 8/20 0.42
KDM4E B2RXH2 5/20 0.42
LMNA P02545 3/20 0.42
PKM P14618 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
GAA P10253 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
SMN1; SMN2 Q16637 5/20 0.39
MEN1 O00255 5/20 0.39
KMT2A Q03164 5/20 0.39
RAB9A P51151 4/20 0.39
NPC1 O15118 3/20 0.39
MAPK1 P28482 3/20 0.39
HPGD P15428 2/20 0.39
ALOX15 P16050 2/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14029305 0.79 AKR1C3 (0.50) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL5008458 0.75 MAPK13 (0.43) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL4412223 0.75 ALDH1A1 (0.43) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL13920985 0.71 MAPK13 (0.45) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL23682701 0.71 ALOX15 (0.46) MAPTKDM4ELMNAPKMRXFP1
SCHEMBL28258520 0.68 MAPT (0.50) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL14029306 0.67 KDM4E (0.45) MAPK14MAPTKDM4ELMNAPKM
SCHEMBL27743294 0.67 MAPK13 (0.40) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL17077674 0.66 MAPK13 (0.71) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL13688636 0.66 MAPT (0.47) MAPK14MAPK13MAPK12MAPK11MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080249301-A1 Regioselective Process for Preparing Benzimidazole Thiophenes SMITHKLINE BEECHAM CORPORATION 2008-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249301-A1 Regioselective Process for Preparing Benzimidazole Thiophenes CYP3A4, CYP2C19, CYP2B6 MAPK14 2162/4885MAPK13 2339/4885MAPK12 1768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.